Related Experiment Videos
Tissue distribution and functional expression of a cDNA encoding a novel mixed lineage kinase
L J Bloem1, T R Pickard, S Acton
1Cardiovascular Discovery Research, Eli Lilly and Company, Indianapolis, IN 46285, USA.
Journal of Molecular and Cellular Cardiology
|September 11, 2001
Summary
Researchers identified a novel kinase, MLK7, involved in cardiac hypertrophy. This protein, expressed in heart cells, activates key signaling pathways, potentially contributing to heart failure progression.
Area of Science:
- Cardiovascular Biology
- Molecular Signaling
- Biochemistry
Background:
- Cardiac hypertrophy is an adaptive heart response to injury or overload, potentially leading to heart failure.
- The specific signaling pathways governing cardiac myocyte hypertrophy are not fully understood.
Purpose of the Study:
- To identify novel signaling molecules involved in cardiac hypertrophy using a human failed heart cDNA library.
- To characterize the function and signaling role of a newly identified kinase, MLK7.
Main Methods:
- Data mining of a human failed heart cDNA library to identify novel genes.
- Expression analysis of MLK7 mRNA in various tissues, focusing on cardiac myocytes.
- In vitro kinase activity assay of recombinant MLK7.
- Expression of MLK7 in cardiac myocytes to assess its effect on signaling pathways and cellular processes.
Main Results:
- A novel kinase, MLK7, belonging to the mixed lineage kinase (MLK) family, was identified.
- MLK7 exhibits serine/threonine kinase activity and is predominantly expressed in cardiac myocytes.
- Expression of MLK7 in cardiac myocytes activates stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) and, to a lesser extent, ERK and p38 pathways.
- MLK7 induces fetal gene expression and increases protein synthesis in cardiac myocytes.
Conclusions:
- MLK7 is a novel member of the mixed lineage kinase family with a significant role in cardiac myocytes.
- MLK7 modulates the cardiac SAPK/JNK signaling pathway.
- MLK7 may play a critical role in the development and progression of cardiac hypertrophy and heart failure.